Author:
Heng Boon Chin,Richards Mark,Shu Yimin,Gribbon Philip
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference37 articles.
1. ABPI (2008) Stem cells in predictive toxicology. A report of a scoping study from the Stem Cells in Predictive Toxicology Task Force, for the Department of Health and the Department of Trade and Industry, United Kingdom. Prepared by The Association of the British Pharmaceutical Industry (ABPI). http://www.sc4sm.org/downloads/SC4PT-REPORT.pdf . Accessed 5 Dec 2008
2. Allegrucci C, Young LE (2007) Differences between human embryonic stem cell lines. Hum Reprod Update 13(2):103–120
3. Araujo RJ (2006) The transnational perspective of the church: the embryonic cloning debate & stem cell research. J Contemp Health Law Policy Spring 22(2):497–507
4. Brambrink T, Foreman R, Welstead GG et al (2008) Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2:151–159
5. Cao T, Lu K, Fu X, Heng BC (2008) Differentiated fibroblastic progenies of human embryonic stem cells for toxicology screening. Cloning Stem Cells 10(1):1–10
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stem Cell and Other Cell Therapies;Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology;2023
2. The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update;International Journal of Molecular Sciences;2021-07-17
3. Evaluation of Stem Cell-Derived Cellular Therapy Products;Toxicologic Pathology;2020-01-10
4. Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications;Cells;2019-04-30
5. Human Pluripotent Stem Cells for Toxicological Screening;Stem Cells in Toxicology and Medicine;2016-10-18